EM18: Research, Development and Innovation in Maternal-Fetal Medicine and Gynecological Oncology

The EM18 group is dedicated to research, development, and innovation in maternal-fetal medicine and gynecological oncology. Its work focuses on improving women's health through applied research and collaboration with healthcare centers and universities.

Responsible researcher

Juan Jesús Fernández Alba:
- E-mail: jjesus.fernandez@uca.es
- ORCID: 0000-0002-7297-6876

Lines of research

Line 1: Diagnosis and management of fetal growth disorders.
Line 2: Quality of life in breast cancer patients.
Line 3: Generic. Epidemiology, evidence-based healthcare intervention, and analysis of results in Maternal-Fetal Medicine and Gynecological Oncology in the Obstetrics and Gynecology Department at Puerto Real University Hospital.

Keywords

# Maternal-fetal diseases
# Breast cancer
# Maternal-fetal medicine

EM18: Research, Development and Innovation in Maternal-Fetal Medicine and Gynecological Oncology

Responsible researcher

Juan Jesús Fernández Alba:

Puerto Real University Hospital: Head of Obstetrics and Gynecology || University of Cádiz: Associate Professor of Health Sciences attached to the Maternal-Child and Radiology Department.

E-mail: jjesus.fernandez@uca.es
ORCID: 0000-0002-7297-6876

Team Members

Principal Investigators:
- Juan Jesús Fernández Alba (PI).
Researchers:
- Angel Vilar Sanchez.
- Carmen González Macías.
- Estefanía Serrano Black.
- Estefanía Soto Pazos.
- María Castillo Lara.
- Rocío Quintero Prado.
- Rocío Moreno Cortés.

EM18: Research, Development and Innovation in Maternal-Fetal Medicine and Gynecological Oncology

Production

Find all of the group's work (their Projects, Patents Publications) on the Andalusian Public Health System's I+Salud Portal: